Overview
- 3 inspections across 3 sites are on record.
- 30 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-09-27.
At a glance
Inspections
3
Sites
3
Observations
30
Career since
Aug 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lyophilization Services of New England, Inc. dba PCI Pharma Services | 27 Sep 2023 | Human Drugs | View 483 → |
| Oxysure Systems, Inc. | 28 Sep 2015 | Medical Devices & Rad Health | View 483 → |
| Octapharma Plasma, Inc. | 10 Aug 2015 | Biologics | View 483 → |
Sites inspected
Lyophilization Services of New England, Inc. dba PCI Pharma ServicesBedford, United States1 insp.
Oxysure Systems, Inc.Frisco, United States1 insp.
Octapharma Plasma, Inc.Fort Worth, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lane V Christensen1 shared
Erik W Koester1 shared
Sean R Marcsisin1 shared
Monique S Frazier1 shared
Amanda J White1 shared
Akbar J Zaidi1 shared
Full investigator report
Get the verbatim findings behind Samuel J Arsenault's 30 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site